Target intelligence / Profile preview

Histone H4 clustered histone 15 (H4C15)

Target
H4C15
Molecular classification
Core histone, Chromatin component, Structural protein, Histone family
01

Overview

Histone H4 clustered histone 15 (H4C15) is a variant of the core histone H4 family, a highly conserved, basic nuclear protein crucial for chromatin structure in eukaryotes[2][4][8]. As part of the nucleosome core, H4C15 interacts with other core histones (H2A, H2B, H3) to organize and compact DNA into chromatin, regulating its accessibility for replication, transcription, and repair[1][3][4][6][8]. Post-translational modifications to H4—such as acetylation and methylation of lysine and arginine residues—finely tune chromatin dynamics and epigenetic gene regulation[1]. Dysregulation of H4 function or modification is linked to genome instability and multiple diseases, notably cancer[1]. H4C15 is not itself a direct therapeutic target but is influenced by drugs that alter histone modification states[1].

Other names
H4 clustered histone 15H4-16H4C1H4C11H4C12H4C13H4C14H4C16H4C2H4C3H4C4H4C5H4C6H4C8H4C9H4/oHIST2H4BLOC112268238
02

Mechanism of action

Inhibition of histone deacetylases increases acetylation of histone H4, leading to relaxed chromatin and increased gene expression. Modulation of histone tail modifications (e.g., methylation, acetylation) regulates access for transcription factors and DNA repair machinery.

03

Biological functions

DNA packagingRegulation of gene expressionChromatin formationDNA replicationEpigenetic regulationNucleosome assembly
04

Disease associations

Cancer (via misregulation or mutation affecting chromatin and genome stability)Possibly neurodegenerative disease (due to defects in chromatin structure and epigenetics)Other (any disease related to altered chromatin or gene expression)
05

Safety considerations

Off-target effects from drugs affecting histone modifications (e.g., HDAC inhibitors) may disrupt global gene expression, leading to toxicity and adverse epigenetic changesNotable risks include cancer, genomic instability, and developmental defects with improper histone regulation
06

Interacting drugs

vorinostat

1 more in the full profile.

07

Biomarkers

Modified histone H4 (acetylation status, methylation patterns) used as biomarkers for cancer, epigenetic dysregulation, and cellular proliferation

Beyond the preview

Go deeper on Histone H4 clustered histone 15 (H4C15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H4 clustered histone 15 (H4C15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call